Vir Biotechnology (MEX:VIR) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:VIR Vir Biotechnology Inc MEX:VIR
52 GF Score
Price MXN170.00
GF Value MXN755.16
! 5 Warning Signs
View Full Analysis

What is Vir Biotechnology Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

MEX:VIR vs AVBP, XNCR, SEPN: Short Interest Comparison

For the Biotechnology subindustry, Vir Biotechnology's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vir Biotechnology Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vir Biotechnology's Short Interest distribution charts can be found below:

* The bar in red indicates where Vir Biotechnology's Short Interest falls into.


MEX:VIR
52GF Score
Vir Biotechnology Inc MEX:VIR
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Vir Biotechnology (MEX:VIR) Overvalued in 2026?

Based on GuruFocus' analysis, Vir Biotechnology stock appears to be undervalued. The current stock price of MXN170.00 is trading 77.5% below its estimated GF Value™ of MXN755.16.

Key valuation signals for MEX:VIR:

  • Short Interest:
  • GF Value™: MXN755.16 vs. price of MXN170.00 (77.5% below fair value)
  • GF Score™: 52/100 with 5 warning signs

No single metric tells the full story. See the MEX:VIR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vir Biotechnology Business Description

Other Exchanges VIR:USA
Address 1800 Owens Street, Suite 900, San Francisco, CA, USA, 94158
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.
52GF Score

Get the complete analysis for MEX:VIR

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN170.00
Price
MXN755.16
GF Value